Genetic Differences May Limit Effectiveness of Widely Used Type 2 Diabetes Drugs, Stanford-Led Research Reveals
More than one in four individuals diagnosed with Type 2 diabetes currently utilize GLP-1 receptor...
Knowledge and News for the Global Fight Against Cancer.
More than one in four individuals diagnosed with Type 2 diabetes currently utilize GLP-1 receptor...
The groundbreaking research, spearheaded by scientists from Flinders University and Greifswald University, has revealed that...
A groundbreaking phase three clinical trial, whose findings were prominently featured in The New England...
People living with established atherosclerotic heart disease who received a shingles vaccine experienced nearly half...
Scientists at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy...
The journey began in 2018 with the identification of T3p, a small RNA molecule uniquely...
Researchers in China have achieved a significant breakthrough in the field of cancer immunotherapy, developing...
A groundbreaking international study, published recently in the prestigious journal Science, has cast a new...
In a significant stride towards combating Alzheimer’s disease, researchers have pinpointed three already approved medications...
A groundbreaking new study has unveiled the alarming presence of microscopic plastic particles in the...